Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSunrise Resources PLC Regulatory News (SRES)

Share Price Information for Sunrise Resources PLC (SRES)

Share Price is delayed by 15 minutes
Get Live Data
0.023    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.004 (19.048%)
Market Cap: £2.16m
SRES Live PriceLast checked at - London Stock Exchange

Intraday Sunrise Resources PLC Share Chart

HAZEN PROJECT UPDATE

15 Sep 2025 09:28

RNS Number : 3297Z
Sunrise Resources Plc
15 September 2025
 

 

SUNRISE RESOURCES PLC

("Sunrise" or the "Company")

 

 

HAZEN PROJECT, NEVADA, USA

 

As announced on 21 July 2025 (the "Announcement"), the Hazen Project is currently under option for sale to a large US-based company which may purchase the project for the sum of US$800,000.

 

Further to the Announcement, the Company can now advise that, by a decision dated 8 September 2025, the Hazen Project has received BLM approval for drill testing. Consequently, the 3-month option period and any option extension periods referred to in the Announcement now run from that decision date.

 

 

Further information:

 

Sunrise Resources plc

Patrick Cheetham, Executive Chairman

Tel: +44 (0)1625 838 884

 

Beaumont Cornish Limited

Nominated Adviser

James Biddle/Roland Cornish

Tel: +44 (0)207 628 3396

 

Peterhouse Capital Limited

Broker

Lucy Williams/Duncan Vasey

 

 

Tel: +44 (0)207 469 0930

Market Abuse Regulation (MAR) Disclosure

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ('MAR'). Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

 

Nominated Adviser

 

Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.

 

Shares in the Company trade on AIM. EPIC: "SRES".

Website: www.sunriseresourcesplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZZGMLRKVGKZG
Date   Source Headline
6th May 20267:00 amRNSISSUE OF WARRANTS
30th Apr 20264:28 pmRNSTotal Voting Rights
23rd Apr 20263:08 pmRNSResult of WRAP Retail Offer
21st Apr 20264:00 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSWRAP Retail Offer for up to £50,000
20th Apr 20263:43 pmRNSHolding(s) in Company
17th Apr 20264:40 pmRNSHolding(s) in Company
17th Apr 20264:07 pmRNSHolding(s) in Company
17th Apr 202612:00 pmRNSHolding(s) in Company
13th Apr 202612:15 pmRNSPlacing and Issue of Equity
26th Mar 202611:16 amRNSVoting at AGM
25th Mar 202610:46 amRNSResult of AGM
23rd Mar 20261:50 pmRNSDIRECTORS’ DEALING
27th Feb 20267:00 amRNSANNUAL REPORT TO 30 SEPTEMBER 2025 & NOTICE OF AGM
20th Feb 202612:30 pmRNSAudited Results for the year to 30 September 2025
4th Feb 20265:56 pmRNSHolding(s) in Company
9th Jan 20269:48 amRNSUPDATE ON HAZEN PROJECT, NEVADA, USA
8th Jan 20267:00 amRNSPIOCHE SEPIOLITE PROJECT, NEVADA, USA
8th Dec 20257:00 amRNSHAZEN PROJECT, NEVADA, USA
3rd Nov 202510:50 amRNS-RGarfield Royalty Interest
31st Oct 20257:00 amRNSPioche Sepiolite Project - Update
28th Oct 20257:00 amRNSNominated Broker
1st Oct 20259:54 amRNSHolding(s) in Company
30th Sep 20252:43 pmRNSTotal Voting Rights
24th Sep 20253:00 pmRNSIssue of Shares following Conversion & TVR
16th Sep 202510:16 amRNSHolding(s) in Company
15th Sep 202510:31 amRNSCS NATURAL POZZOLAN PROJECT UPDATE
15th Sep 20259:28 amRNSHAZEN PROJECT UPDATE
7th Aug 202512:17 pmRNSHolding(s) in Company
1st Aug 20252:00 pmRNSResult of WRAP Retail Offer
31st Jul 20257:01 amRNSWRAP Retail Offer launches
31st Jul 20257:00 amRNSPlacing raised £200k, launch of WRAP retail offer
23rd Jul 20257:00 amRNSPioche Sepiolite Project - Update
21st Jul 20257:00 amRNSSale Option Agreement – Hazen Project
14th Jul 20253:25 pmRNSHolding(s) in Company
9th Jun 20257:00 amRNSConvertible Security – Extension of Term
3rd Jun 20252:03 pmRNS-RGarfield Royalty Interest
21st May 20257:00 amRNSHALF-YEARLY REPORT 2025
15th Apr 202512:00 pmRNSPioche Sepiolite Project – Positive Test Results
9th Apr 20257:00 amRNS-RGold & Silver Projects
2nd Apr 202512:00 pmRNS-RPioche Sepiolite Project
31st Mar 202510:32 amRNSDirectorate Change
31st Mar 20258:49 amRNSTotal Voting Rights
14th Mar 20254:44 pmRNSVoting at AGM
13th Mar 202511:50 amRNSResult of AGM
12th Mar 202512:07 pmRNSDIRECTORS’ DEALINGS, ISSUE OF EQUITY & TVR
10th Mar 202512:00 pmRNSAppointment of Non-Executive Director
28th Feb 20251:29 pmRNSTotal Voting Rights
17th Feb 20255:16 pmRNSIssue of Shares following Conversion & TVR
14th Feb 202511:00 amRNSANNUAL REPORT & NOTICE OF 2025 AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.